Expert Opinion on Pharmacotherapy, Volume 11, Issue 18 (2010)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Pharmacotherapy, Volume 11, Issue 18 (2010)

See all volumes and issues
Vol 25, 2024 Vol 24, 2023 Vol 23, 2022 Vol 22, 2021 Vol 21, 2020 Vol 20, 2019 Vol 19, 2018 Vol 18, 2017 Vol 17, 2016 Vol 16, 2015 Vol 15, 2014 Vol 14, 2013 Vol 13, 2012 Vol 12, 2011 Volume 11, 2010 Vol 10, 2009 Vol 9, 2008 Vol 8, 2007 Vol 7, 2006 Vol 6, 2005 Vol 5, 2004 Vol 4, 2003 Vol 3, 2002 Vol 2, 2001 Vol 1, 1999-2000
Download citations Download PDFs Download issue

Editorial

Article
To switch (statins) or not to switch? That is the question
Vasilios G Athyros, Konstantinos Tziomalos, Asterios Karagiannis & Dimitri P Mikhailidis
Pages: 2943-2946
Published online: 19 Oct 2010
AbstractforTo switch (statins) or not to switch? That is the question | Full Text | References | PDF (163.7 KB)
  • 196 Views
  • 7 CrossRef citations
  • 0Altmetric

Original Research

Article
Clinical evolution of substance use disorder patients during treatment with quetiapine: a 12-week, open-label, naturalistic trial
Élie Rizkallah MSc, Emmanuel Stip MD MSc, Simon Zhornitsky PhD, Tania Pampoulova MD MSc, Alain Gendron PhD, Pierre-Paul Rompré PhD, Jean-Pierre Chiasson MD & Stéphane Potvin PhD
Pages: 2947-2951
Published online: 28 Oct 2010
AbstractforClinical evolution of substance use disorder patients during treatment with quetiapine: a 12-week, open-label, naturalistic trial | Full Text | References | PDF (179.2 KB)
  • 154 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
An open-label comparison of the efficacy and safety of certoparin versus unfractionated heparin for the prevention of thromboembolic complications in acutely ill medical patients: CERTAIN
Sebastian M Schellong, Sylvia Haas, Andreas Greinacher, Uta Schwanebeck, Christian Sieder, Claudia Abletshauser, Peter Bramlage & Hanno Riess
Pages: 2953-2961
Published online: 18 Oct 2010
AbstractforAn open-label comparison of the efficacy and safety of certoparin versus unfractionated heparin for the prevention of thromboembolic complications in acutely ill medical patients: CERTAIN | Full Text | References | PDF (202.7 KB)
  • 244 Views
  • 17 CrossRef citations
  • 0Altmetric

Reviews

Article
Emerging sublingual immunotherapy drugs
Enrico Compalati MD PhD, Anthi Rogkakou, Elisa Villa, Giovanni Passalacqua & Giorgio Walter Canonica
Pages: 2963-2972
Published online: 19 Oct 2010
AbstractforEmerging sublingual immunotherapy drugs | Full Text | References | PDF (307.3 KB)
  • 101 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Pharmacological treatment of obesity in children and adolescents: current status and perspectives
Natalia Catoira, Mara Nagel, Guillermo Di Girolamo & Claudio D Gonzalez
Pages: 2973-2983
Published online: 19 Oct 2010
AbstractforPharmacological treatment of obesity in children and adolescents: current status and perspectives | Full Text | References | PDF (223.6 KB)
  • 386 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Probiotic strategies for the treatment and prevention of bacterial vaginosis
Roderick A MacPhee BScH, Ruben Hummelen MSc, Jordan E Bisanz BMScH, Wayne L Miller PhD & Gregor Reid PhD MBA Dr HS FCAHS
Pages: 2985-2995
Published online: 17 Nov 2010
AbstractforProbiotic strategies for the treatment and prevention of bacterial vaginosis | Full Text | References | PDF (225.8 KB)
  • 880 Views
  • 54 CrossRef citations
  • 0Altmetric
Article
Advances in chemotherapy in advanced non-small-cell lung cancer
Paolo Maione MD, Antonio Rossi MD, Paola Claudia Sacco MD, Maria Anna Bareschino MD, Clorinda Schettino MD & Cesare Gridelli MD
Pages: 2997-3007
Published online: 12 Aug 2010
AbstractforAdvances in chemotherapy in advanced non-small-cell lung cancer | Full Text | References | PDF (221 KB)
  • 285 Views
  • 26 CrossRef citations
  • 0Altmetric
Article
Invasive community-associated MRSA infections: epidemiology and antimicrobial management
Solen Pichereau PharmD MS & Warren E Rose PharmD
Pages: 3009-3025
Published online: 19 Oct 2010
AbstractforInvasive community-associated MRSA infections: epidemiology and antimicrobial management | Full Text | References | PDF (262.5 KB)
  • 535 Views
  • 19 CrossRef citations
  • 0Altmetric
Article
Treating gestational trophoblastic disease
Noah Rodriguez, Donald P Goldstein & Ross S Berkowitz
Pages: 3027-3039
Published online: 19 Oct 2010
AbstractforTreating gestational trophoblastic disease | Full Text | References | PDF (236.7 KB)
  • 265 Views
  • 7 CrossRef citations
  • 0Altmetric
Article
Pharmacotherapy of dyslipidemias in the adult population
Giovanni Battista Vigna MD PhD & Renato Fellin MD
Pages: 3041-3052
Published online: 19 Oct 2010
AbstractforPharmacotherapy of dyslipidemias in the adult population | Full Text | References | PDF (231.8 KB)
  • 151 Views
  • 7 CrossRef citations
  • 0Altmetric

Drug Evaluations

Article
Sertindole for the treatment of schizophrenia
Jean-Michel Azorin, Arthur Kaladjian, Eric Fakra & Marc Adida
Pages: 3053-3064
Published online: 17 Nov 2010
AbstractforSertindole for the treatment of schizophrenia | Full Text | References | PDF (270.8 KB)
  • 187 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
Nilotinib for the treatment of Philadelphia-chromosome-positive chronic myeloid leukemia
Amber Fullmer, Hagop Kantarjian, Jorge Cortes & Elias Jabbour MD
Pages: 3065-3072
Published online: 13 Nov 2010
AbstractforNilotinib for the treatment of Philadelphia-chromosome-positive chronic myeloid leukemia | Full Text | References | PDF (231.1 KB)
  • 199 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Emerging role of the histone deacetylase inhibitor romidepsin in hematologic malignancies
Nitin Jain & Olatoyosi Odenike
Pages: 3073-3084
Published online: 17 Nov 2010
AbstractforEmerging role of the histone deacetylase inhibitor romidepsin in hematologic malignancies | Full Text | References | PDF (254.6 KB)
  • 263 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Where is dihydroergotamine mesylate in the changing landscape of migraine therapy?
John A Morren MD & Nestor Galvez-Jimenez MD MSc MHSA FACP
Pages: 3085-3093
Published online: 17 Nov 2010
AbstractforWhere is dihydroergotamine mesylate in the changing landscape of migraine therapy? | Full Text | References | PDF (251.6 KB)
  • 420 Views
  • 22 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Asthma management with triple ICS/LABA/LAMA combination to reduce the risk of exacerbation: an umbrella review compliant with the PRIOR statement
Rossella Laitano et al.
Review Article | Published online: 16 Jun 2024
Upadacitinib in Crohn’s disease: needs more insight
Avinash Tiwari
Letter to the Editor | Published online: 14 Jun 2024
Free Access
Elinzanetant, a new combined neurokinin-1/-3 receptor antagonist for the treatment of postmenopausal vasomotor symptoms
Marlene Hager et al.
Review Article | Published online: 13 Jun 2024
The effects of prenatal exposure to opioids on early childhood development: context matters most
Ginny Carter et al.
Review Article | Published online: 13 Jun 2024
View all latest articles